James Schaub
2018
In 2018, James Schaub earned a total compensation of $498.3K as EVP and Chief Operating Officer at RVL Pharmaceuticals plc.
Compensation breakdown
| Non-Equity Incentive Plan | $131,404 |
|---|---|
| Salary | $347,692 |
| Other | $19,196 |
| Total | $498,292 |
Schaub received $347.7K in salary, accounting for 70% of the total pay in 2018.
Schaub also received $131.4K in non-equity incentive plan and $19.2K in other compensation.
Rankings
In 2018, James Schaub's compensation ranked 11,893rd out of 14,244 executives tracked by ExecPay. In other words, Schaub earned more than 16.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,893 out of 14,244 | 17th |
Division Manufacturing | 4,819 out of 5,765 | 16th |
Major group Chemicals And Allied Products | 1,827 out of 2,128 | 14th |
Industry group Drugs | 1,560 out of 1,817 | 14th |
Industry Pharmaceutical Preparations | 1,196 out of 1,391 | 14th |
Source: SEC filing on April 20, 2020.
Schaub's colleagues
We found three more compensation records of executives who worked with James Schaub at RVL Pharmaceuticals plc in 2018.
News
RVL Pharmaceuticals plc Former EVP, Research & Development Tina deVries' 2022 pay slips 19% to $561K
April 24, 2023
RVL Pharmaceuticals plc CEO Brian Markison's 2021 pay falls 63% to $1.4M
April 25, 2022
RVL Pharmaceuticals plc CEO Brian Markison's 2020 pay slips 12% to $3.8M
April 26, 2021
RVL Pharmaceuticals plc CEO Brian Markison's 2019 pay jumps 291% to $4.3M
April 20, 2020
RVL Pharmaceuticals plc CEO Brian Markison's 2018 pay slips 10% to $1.1M
April 26, 2019